link
Bookmarks
Screening in 5th Decade (40-49 Years)
Amy M. Fowler, MD, PhD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
2
6
4
0

KEY FACTS

  • Imaging

    • Top Differential Diagnoses

      • Clinical Issues

        • Diagnostic Checklist

          TERMINOLOGY

          • Abbreviations

            • American Cancer Society (ACS)
            • American College of Obstetricians and Gynecologists (ACOG)
            • American College of Radiology (ACR)
            • Cancer Intervention and Surveillance Modeling Network (CISNET)
            • National Mammography Database (NMD)
            • National Comprehensive Cancer Network (NCCN)
            • Surveillance, Epidemiology, End Results (SEER)
            • United States Preventive Services Task Force (USPSTF)
          • Definitions

            • Recall rate: Percentage of screening exams recommended for additional imaging (i.e., BI-RADS 0 assessment)
            • Overdiagnosis: Screen detection of cancers that would not have become clinically apparent during patient's lifetime

          IMAGING

          • Imaging Recommendations

            DIFFERENTIAL DIAGNOSIS

              CLINICAL ISSUES

              • Demographics

                • Natural History & Prognosis

                  • Treatment

                    DIAGNOSTIC CHECKLIST

                    • Consider

                      • Reporting Tips

                        Selected References

                        1. Ahn S et al: Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. ePub, 2018
                        2. Destounis S et al: Age to begin and intervals for breast cancer screening: Balancing benefits and harms. AJR Am J Roentgenol. 210(2):279-284, 2018
                        3. Giess CS et al: Patient, radiologist, and examination characteristics affecting screening mammography recall rates in a large academic practice. J Am Coll Radiol. ePub, 2018
                        4. Ray KM et al: Screening mammography in women 40-49 years old: Current evidence. AJR Am J Roentgenol. 210(2):264-270, 2018
                        5. van den Broek JJ et al: Comparing CISNET breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49. Med Decis Making. 38(1_suppl):140S-150S, 2018
                        6. Arleo EK et al: Comparison of recommendations for screening mammography using CISNET models. Cancer. 123(19):3673-3680, 2017
                        7. Committee on Practice bulletins—Gynecology.: Practice bulletin number 179: Breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 130(1):e1-e16, 2017
                        8. Lee CS et al: Association of patient age with outcomes of current-era, large-scale screening mammography: Analysis of data from the National Mammography Database. JAMA Oncol. 3(8):1134-1136, 2017
                        9. Monticciolo DL et al: Breast cancer screening for average-risk women: recommendations from the ACR Commission on Breast Imaging. J Am Coll Radiol. 14(9):1137-1143, 2017
                        10. Rafferty EA et al: Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography. Breast Cancer Res Treat. 164(3):659-666, 2017
                        11. Bjurstam NG et al: Updated results of the Gothenburg Trial of Mammographic Screening. Cancer. 122(12):1832-5, 2016
                        12. Hayward JH et al: Improving Screening Mammography Outcomes Through Comparison With Multiple Prior Mammograms. AJR Am J Roentgenol. 207(4):918-924, 2016
                        13. Mandelblatt JS et al: Collaborative modeling of the benefits and harms associated with different u.s. breast cancer screening strategies. Ann Intern Med. 164(4):215-25, 2016
                        14. Nelson HD et al: Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 164(4):226-35, 2016
                        15. Siu AL et al: Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 164(4):279-96, 2016
                        16. Hakim CM et al: Effect of the Availability of Prior Full-Field Digital Mammography and Digital Breast Tomosynthesis Images on the Interpretation of Mammograms. Radiology. 276(1):65-72, 2015
                        17. Miglioretti DL et al: Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol. 1(8):1069-77, 2015
                        18. Moss SM et al: Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Lancet Oncol. 16(9):1123-1132, 2015
                        19. Oeffinger KC et al: Breast cancer screening for women at average risk: 2015 guideline update From the American Cancer Society. JAMA. 314(15):1599-614, 2015
                        20. Price ER et al: The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old. AJR Am J Roentgenol. 205(6):1360-4, 2015
                        21. Yaffe MJ et al: Clinical outcomes of modelling mammography screening strategies. Health Rep. 26(12):9-15, 2015
                        22. Ayvaci MU et al: Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 14:584, 2014
                        23. Coldman A et al: Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 106(11), 2014
                        24. Destounis SV et al: Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility. AJR Am J Roentgenol. 202(4):928-32, 2014
                        25. Hendrick RE et al: Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old. AJR Am J Roentgenol. 203(6):1379-81, 2014
                        26. Hellquist BN et al: Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 117(4):714-22, 2011
                        27. Hendrick RE et al: United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 196(2):W112-6, 2011
                        28. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 257(1):246-53, 2010
                        29. Burnside ES et al: The use of batch reading to improve the performance of screening mammography. AJR 185:790-6, 2005
                        30. Pisano ED et al: Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 353:1773-83, 2005
                        31. Tabar L et al: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 361:1405-10, 2003
                        32. Ernster VL et al: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-54, 2002
                        33. Andersson I et al: Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr. 63-7, 1997
                        34. Feig SA et al: Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 119-24, 1997
                        35. Hendrick RE, et al: Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 22:87-92, 1997
                        36. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Int J Cancer. 68(6):693-9, 1996
                        37. Smart CR et al: Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 75(7):1619-26, 1995
                        38. Tabar L et al: Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 75(10):2507-17, 1995
                        Related Anatomy
                        Loading...
                        Related Differential Diagnoses
                        Loading...
                        References
                        Tables

                        Tables

                        KEY FACTS

                        • Imaging

                          • Top Differential Diagnoses

                            • Clinical Issues

                              • Diagnostic Checklist

                                TERMINOLOGY

                                • Abbreviations

                                  • American Cancer Society (ACS)
                                  • American College of Obstetricians and Gynecologists (ACOG)
                                  • American College of Radiology (ACR)
                                  • Cancer Intervention and Surveillance Modeling Network (CISNET)
                                  • National Mammography Database (NMD)
                                  • National Comprehensive Cancer Network (NCCN)
                                  • Surveillance, Epidemiology, End Results (SEER)
                                  • United States Preventive Services Task Force (USPSTF)
                                • Definitions

                                  • Recall rate: Percentage of screening exams recommended for additional imaging (i.e., BI-RADS 0 assessment)
                                  • Overdiagnosis: Screen detection of cancers that would not have become clinically apparent during patient's lifetime

                                IMAGING

                                • Imaging Recommendations

                                  DIFFERENTIAL DIAGNOSIS

                                    CLINICAL ISSUES

                                    • Demographics

                                      • Natural History & Prognosis

                                        • Treatment

                                          DIAGNOSTIC CHECKLIST

                                          • Consider

                                            • Reporting Tips

                                              Selected References

                                              1. Ahn S et al: Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. ePub, 2018
                                              2. Destounis S et al: Age to begin and intervals for breast cancer screening: Balancing benefits and harms. AJR Am J Roentgenol. 210(2):279-284, 2018
                                              3. Giess CS et al: Patient, radiologist, and examination characteristics affecting screening mammography recall rates in a large academic practice. J Am Coll Radiol. ePub, 2018
                                              4. Ray KM et al: Screening mammography in women 40-49 years old: Current evidence. AJR Am J Roentgenol. 210(2):264-270, 2018
                                              5. van den Broek JJ et al: Comparing CISNET breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49. Med Decis Making. 38(1_suppl):140S-150S, 2018
                                              6. Arleo EK et al: Comparison of recommendations for screening mammography using CISNET models. Cancer. 123(19):3673-3680, 2017
                                              7. Committee on Practice bulletins—Gynecology.: Practice bulletin number 179: Breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 130(1):e1-e16, 2017
                                              8. Lee CS et al: Association of patient age with outcomes of current-era, large-scale screening mammography: Analysis of data from the National Mammography Database. JAMA Oncol. 3(8):1134-1136, 2017
                                              9. Monticciolo DL et al: Breast cancer screening for average-risk women: recommendations from the ACR Commission on Breast Imaging. J Am Coll Radiol. 14(9):1137-1143, 2017
                                              10. Rafferty EA et al: Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography. Breast Cancer Res Treat. 164(3):659-666, 2017
                                              11. Bjurstam NG et al: Updated results of the Gothenburg Trial of Mammographic Screening. Cancer. 122(12):1832-5, 2016
                                              12. Hayward JH et al: Improving Screening Mammography Outcomes Through Comparison With Multiple Prior Mammograms. AJR Am J Roentgenol. 207(4):918-924, 2016
                                              13. Mandelblatt JS et al: Collaborative modeling of the benefits and harms associated with different u.s. breast cancer screening strategies. Ann Intern Med. 164(4):215-25, 2016
                                              14. Nelson HD et al: Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 164(4):226-35, 2016
                                              15. Siu AL et al: Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 164(4):279-96, 2016
                                              16. Hakim CM et al: Effect of the Availability of Prior Full-Field Digital Mammography and Digital Breast Tomosynthesis Images on the Interpretation of Mammograms. Radiology. 276(1):65-72, 2015
                                              17. Miglioretti DL et al: Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol. 1(8):1069-77, 2015
                                              18. Moss SM et al: Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Lancet Oncol. 16(9):1123-1132, 2015
                                              19. Oeffinger KC et al: Breast cancer screening for women at average risk: 2015 guideline update From the American Cancer Society. JAMA. 314(15):1599-614, 2015
                                              20. Price ER et al: The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old. AJR Am J Roentgenol. 205(6):1360-4, 2015
                                              21. Yaffe MJ et al: Clinical outcomes of modelling mammography screening strategies. Health Rep. 26(12):9-15, 2015
                                              22. Ayvaci MU et al: Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 14:584, 2014
                                              23. Coldman A et al: Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 106(11), 2014
                                              24. Destounis SV et al: Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility. AJR Am J Roentgenol. 202(4):928-32, 2014
                                              25. Hendrick RE et al: Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old. AJR Am J Roentgenol. 203(6):1379-81, 2014
                                              26. Hellquist BN et al: Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 117(4):714-22, 2011
                                              27. Hendrick RE et al: United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol. 196(2):W112-6, 2011
                                              28. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 257(1):246-53, 2010
                                              29. Burnside ES et al: The use of batch reading to improve the performance of screening mammography. AJR 185:790-6, 2005
                                              30. Pisano ED et al: Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 353:1773-83, 2005
                                              31. Tabar L et al: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 361:1405-10, 2003
                                              32. Ernster VL et al: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-54, 2002
                                              33. Andersson I et al: Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr. 63-7, 1997
                                              34. Feig SA et al: Radiation risk from screening mammography of women aged 40-49 years. J Natl Cancer Inst Monogr. 119-24, 1997
                                              35. Hendrick RE, et al: Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 22:87-92, 1997
                                              36. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Int J Cancer. 68(6):693-9, 1996
                                              37. Smart CR et al: Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 75(7):1619-26, 1995
                                              38. Tabar L et al: Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 75(10):2507-17, 1995